High incidence of α-Mannosidosis in ‘MPS-like’ phenotypes

2. September 2020

α-Mannosidosis is an inherited lysosomal storage disorder caused by genetic mutations leading to limited or no expression of a...

Read more

Diagnostic Strategy for Females Suspected of Fabry Disease

18. August 2020

Fabry disease (FD) is a X-linked inherited disorder where deficiency of the α-Galactosidase A (α-Gal A) enzyme causes Globotriaosylceramide...

Read more

OPEN LETTER – We stay open for you and your patients – Please read

15. March 2020

We stay open for you and your patients! We used the last days to prepare us to continue our...

Read more

amedes and ARCHIMEDlife – a new strong international alliance

17. January 2020

ARCHIMEDlife is very proud to announce the strategic alliance with amedes Holding GmbH, a leading provider in interdisciplinary and...

Read more

ARCHIMEDlife and Blueprint Genetics – partnership in North America

25. September 2019

Combining high-quality biochemical testing with innovative genetic testing forms a powerful tool for personalized medicine, clinical research and diagnostics...

Read more

First LEA assay launched

14. March 2018

LEA2 MPS Panel Our first LEA2 (Lysosomal Enzyme Activity) assay has now been started and with it several mucopolysaccharidoses...

Read more

Awarded work: Hemoglobinopathies and Thalassemias

14. March 2018

Our awarded work (Poster Finalist at MSACL Europe, also see the PDF Poster Hemoglobinopathies_MSACL) on hemoglobinopathies and thalassemias is now...

Read more

Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine (Lyso-Gb3) and time to initiation of enzyme replacement therapy, an observational study

7. March 2018

Introduction: Methods: Results:  Conclusion: Authors / corresponding author*  JAlbinaNowakaSarah H.HailebDavid C.KaspercThomas P.MechtlercAndreas J.FlammeraPierre A.KrayenbuehldDaniel P.Franzena   University Hospital Zurich,...

Read more

Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium

7. March 2018

The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients,...

Read more

5 years ARCHIMEDlife – Thanks to our partners, clients and friends!

21. November 2017

The 21st of November 2017  is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve...

Read more